CTCL
Clinical trials for CTCL explained in plain language.
Never miss a new study
Get alerted when new CTCL trials appear
Sign up with your email to follow new studies for CTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat skin cancer: PTX-100 enters phase 2 trial
Disease control Recruiting nowThis phase 2 trial tests a drug called PTX-100 in 115 adults with relapsed or refractory cutaneous T-cell lymphoma (CTCL), a rare type of skin cancer. Participants receive PTX-100 by IV infusion over several cycles. The goal is to see if the drug can shrink or eliminate tumors an…
Matched conditions: CTCL
Phase: PHASE2 • Sponsor: Prescient Therapeutics, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Light-Activated gel shows promise for rare skin cancer
Disease control Recruiting nowThis Phase 3 trial tests a gel called HyBryte, which is activated by visible light, for treating cutaneous T-cell lymphoma (CTCL), a rare type of skin cancer. About 80 adults with early-stage CTCL will apply the gel or a placebo twice a week for 18 weeks, then receive light treat…
Matched conditions: CTCL
Phase: PHASE3 • Sponsor: Soligenix • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New gel could help cancer patients ditch steroid creams
Symptom relief Recruiting nowThis study is testing whether a special gel called StrataCTX can help people with skin reactions from cutaneous T-cell lymphoma (CTCL) or cancer treatments use less steroid cream. Steroid creams can have side effects when used a lot, so finding an alternative is important. The st…
Matched conditions: CTCL
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC